Neuroimmunology
Publications (139)
Fernández-Velasco, JI; Kuhle, J; Monreal, E; Meca-Lallana, V; Meca-Lallana, J; Izquierdo, G; Gascón-Giménez, F; de la Maza, SS; Walo-Delgado, PE; Maceski, A; Rodríguez-Martín, E; Roldán, E; Villarrubia, N; Saiz, A; Blanco, Y; Sánchez, P; Carreón-Guarnizo, E; Aladro, Y; Brieva, L; Iniguez, C; González-Suárez, I; de Antonio, LAR; Masjuan, J; Costa-Frossard, L; Villar, LM
Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MS
Neurology-Neuroimmunology & Neuroinflammation 8 940-. .
Purroy F; Vicente-Pascual M; Arque G; Baraldes-Rovira M; Begue R; Gallego Y; Gil MI; Gil-Villar MP; Mauri G; Quilez A; Sanahuja J; Vazquez-Justes D
Sex-Related Differences in Clinical Features, Neuroimaging, and Long-Term Prognosis After Transient Ischemic Attack.
STROKE 52 424-433. .
Casado V.; Bonaventura I.; Brieva L.; Martínez-Yélamos S.; Martín G.; Presas-Rodriguez S.; Hervas M.; Hernández J.J.; Munteis E.; Escartin A.; Gubieras L.; Mañé-Martínez M.A.; Ramió-Torrentà L.
Costes directos de los brotes en pacientes con esclerosis múltiple remitente-recurrente
Neurology Perspectives 1 160-169. .
Otero-Romero, S; Rodríguez-García, J; Vilella, A; Ara, JR; Brieva, L; Calles, C; Carmona, O; Casanova, V; Costa-Frossard, L; Eichau, S; García-Merino, JA; Garcia-Vidal, C; González-Platas, M; Llaneza, M; Martínez-Ginés, M; Meca-Lallana, JE; Prieto, JM; Rodríguez-Antigüedad, A; Tintoré, M; Blanco, Y; Moral, E
Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement
NEUROLOGIA 36 50-60. .
Avila, A; Pastor, P; Planellas, L; Gil-Villar, MP; Hernández-Vara, J; Fernández-Dorado, A
DISCREPA study: treatment of advanced Parkinson's disease and use of second-line treatments in Catalonia
REVISTA DE NEUROLOGIA 72 1-8. .
Meca-Lallana, J; Maurino, J; Hernández-Pérez MÁ; Sempere, AP; Brieva, L; García-Arcelay E; Terzaghi, M; Saposnik, G; Ballesteros, J
Psychometric Properties of the SymptoMScreen Questionnaire in a Mild Disability Population of Patients with Relapsing-Remitting Multiple Sclerosis: Quantifying the Patient's Perspective.
Neurology and Therapy 9 173-179. .
Vazquez-Justes, D; Carreño-Gago L; Garcia-Arum, E; Traveset, A; Montoya, J; Ruiz-Pesini, E; Lopez, R; Brieva, L
Mitochondrial m.13513G > A Point Mutation in ND5 in a 16-Year-Old Man with Leber Hereditary Optic Neuropathy Detected by Next-Generation Sequencing
Journal of Pediatric Genetics 8 231-234. .
Gonzalo, H; Nogueras, L; Gil-Sanchez, A; Hervas, JV; Valcheva, P; Gonzalez-Mingot, C; Martin-Gari, M; Canudes, M; Peralta, S; Solana, MJ; Pamplona, R; Portero-Otin, M; Boada, J; Serrano JCE; Brieva, L
Impairment of Mitochondrial Redox Status in Peripheral Lymphocytes of Multiple Sclerosis Patients
Frontiers in Neuroscience 13 938-938. .
Nogueras, L; Gonzalo, H; Jove, M; Sol, J; Gil-Sanchez, A; Hervas, JV; Valcheva, P; Gonzalez-Mingot, C; Solana, MJ; Peralta, S; Pamplona, R; Brieva, L
Lipid profile of cerebrospinal fluid in multiple sclerosis patients: a potential tool for diagnosis
Scientific Reports 9 11313-11313. .
Hervas-Garcia, JV; Pagani-Cassara, F
Chronic relapsing inflammatory optic neuropathy: a literature review
REVISTA DE NEUROLOGIA 68 524-530. .
Oreja-Guevara, C; Ayuso Blanco T; Brieva Ruiz L; Hernández Pérez MÁ; Meca-Lallana, V; Ramió-Torrentà L
Cognitive Dysfunctions and Assessments in Multiple Sclerosis
Frontiers in Neurology 10 581-581. .
Fernandez, O; Tintore, M; Saiz, A; Calles-Hernandez, MC; Comabella, M; Ramio-Torrenta, L; Oterino, A; Izquierdo, G; Tellez, N; Garcia-Merino JA; Brieva, L; Arnal-Garcia, C; Aladro, Y; Mendibe-Bilbao, MD; Meca-Lallana, JE; Romero-Pinel, L; Martinez-Gines, ML; Arroyo, R; Oreja-Guevara, C; Costa-Frossard, L; Carrascal, P; Rodriguez-Antiguedad, A
Review of the novelties presented at the 2018 ECTRIMS Congress: 11th Post-ECTRIMS Meeting (II)
REVISTA DE NEUROLOGIA 68 468-479. .
